Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.
Study Goal
The researchers aimed to compare the effectiveness of mindfulness-based cognitive therapy (MBCT) versus an active control condition (ACC) in preventing depression relapse, reducing depressive symptoms, and improving life satisfaction.
Results Summary
MBCT did not differ from ACC in depression relapse rates or symptom reduction, but the trajectory of symptom improvement differed—ACC showed immediate post-intervention reduction followed by gradual increase, while MBCT showed gradual linear reduction. Both groups had equal improvements in life satisfaction.
Population
92 participants in remission from major depressive disorder with residual depressive symptoms.
Effective Dosage
Not specified (8-week structured program).
Duration
8-week intervention with 60-week follow-up.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based cognitive therapy (MBCT) | no change | depression relapse rates | participants in remission from major depressive disorder with residual depressive symptoms | - | no differences | #1 |
mindfulness-based cognitive therapy (MBCT) | no change | time to relapse | participants in remission from major depressive disorder with residual depressive symptoms | - | no differences | #2 |
mindfulness-based cognitive therapy (MBCT) | decrease | depressive symptoms | participants in remission from major depressive disorder with residual depressive symptoms | - | significant reductions | #3 |
mindfulness-based cognitive therapy (MBCT) | increase | life satisfaction | participants in remission from major depressive disorder with residual depressive symptoms | - | improvements | #4 |
mindfulness-based cognitive therapy (MBCT) | decrease | depressive symptoms | participants in remission from major depressive disorder with residual depressive symptoms | - | gradual linear symptom reduction | #5 |
active control condition (ACC) | no change | depression relapse rates | participants in remission from major depressive disorder with residual depressive symptoms | - | no differences | #6 |
active control condition (ACC) | no change | time to relapse | participants in remission from major depressive disorder with residual depressive symptoms | - | no differences | #7 |
active control condition (ACC) | decrease | depressive symptoms | participants in remission from major depressive disorder with residual depressive symptoms | - | significant reductions | #8 |
active control condition (ACC) | increase | life satisfaction | participants in remission from major depressive disorder with residual depressive symptoms | - | improvements | #9 |
active control condition (ACC) | decrease then increase | depressive symptoms | participants in remission from major depressive disorder with residual depressive symptoms | - | immediate symptom reduction postintervention and then a gradual increase | #10 |
OBJECTIVE: We evaluated the comparative effectiveness of mindfulness-based cognitive therapy (MBCT) versus an active control condition (ACC) for depression relapse prevention, depressive symptom reduction, and improvement in life satisfaction. METHOD: Ninety-two participants in remission from major depressive disorder with residual depressive symptoms were randomized to either an 8-week MBCT or a validated ACC that is structurally equivalent to MBCT and controls for nonspecific effects (e.g., interaction with a facilitator, perceived social support, treatment outcome expectations). Both interventions were delivered according to their published manuals. RESULTS: Intention-to-treat analyses indicated no differences between MBCT and ACC in depression relapse rates or time to relapse over a 60-week follow-up. Both groups experienced significant and equal reductions in depressive symptoms and improvements in life satisfaction. A significant quadratic interaction (Group × Time) indicated that the pattern of depressive symptom reduction differed between groups. The ACC experienced immediate symptom reduction postintervention and then a gradual increase over the 60-week follow-up. The MBCT group experienced a gradual linear symptom reduction. The pattern for life satisfaction was identical but only marginally significant. CONCLUSIONS: MBCT did not differ from an ACC on rates of depression relapse, symptom reduction, or life satisfaction, suggesting that MBCT is no more effective for preventing depression relapse and reducing depressive symptoms than the active components of the ACC. Differences in trajectory of depressive symptom improvement suggest that the intervention-specific skills acquired may be associated with differential rates of therapeutic benefit. This study demonstrates the importance of comparing psychotherapeutic interventions to active control conditions.